Skip to main content

Table 3 Short-term outcomes of all patients following various multidisciplinary approaches

From: The efficiency of electronic list-based multidisciplinary team meetings in management of gastrointestinal malignancy: a single-center experience in Southern China

  eMDT group (n = 2156) cMDT group (n = 1518) P value
Including Period 01/01/16–31/12/16 01/01/15–31/12/15  
 Accuracy in tumor staginga, ratio(%)    0.070
  Stage I 326/372 (87.6) 231/266 (86.8) 0.810
  Stage II 699/854 (81.8) 386/555 (69.5) < 0.001
  Stage III 472/620 (76.1) 289/450 (64.2) < 0.001
  Stage IV 292/310 (94.2) 231/247 (93.5) 0.859
 Overall LOS, days 12.0 ± 7.5 15.1 ± 10.4 < 0.001
  Esophageal cancer 15.5 ± 6.8 18.7 ± 9.4 < 0.001
  Gastric cancer 16.1 ± 8.4 20.3 ± 10.3 < 0.001
  Colorectal cancer 10.4 ± 3.1 13.8 ± 8.3 < 0.001
  Other malignancies 7.3 ± 10.2 8.6 ± 11.8 0.161
 Overall LOPS, daysb 8.1 ± 7.2 10.8 ± 8.7 < 0.001
  Esophageal cancer 10.2 ± 6.9 12.9 ± 7.2 0.003
  Gastric cancer 11.5 ± 5.2 13.8 ± 6.9 < 0.001
  Colorectal cancer 6.3 ± 4.1 9.8 ± 5.7 < 0.001
  Other malignancies 6.1 ± 9.2 7.8 ± 9.3 0.031
 Complications, n(%) 383 (17.6) 293 (19.3) 0.243
  Bowel obstruction 206 (9.6) 147 (9.7) 0.910
  SSI 125 (5.8) 90 (5.9) 0.887
  IAH 28 (1.3) 26 (1.7) 0.331
  Othersc 43 (2.0) 31 (2.0) 0.906
 Unplanned reoperation, n(%) 21 (1.0) 16 (1.0) 0.867
  1. LOS length of stay, LOPS length of postoperative stay, SSI surgical site infection, IAH intra-abdominal hemorrhage
  2. aPercentage of correct stage in clinical staging as the pathological stage
  3. bPatients receiving definitive operation were included for group comparison, with 1888 and 1336 cases in eMDT and cMDT groups respectively
  4. cOther complications include fever, pulmonary infection, deep vein thrombosis, urinary tract infection and so on. Data are expressed as number (%) or means ± SD, where appropriate